Domain > www.propanc.com

More information on this domain is in AlienVault OTX

DNS Resolutions

Date	IP Address
2019-11-18	52.72.244.253 (ClassC)
2020-05-16	35.175.4.16 (ClassC)
2020-07-15	54.227.147.28 (ClassC)
2022-02-24	3.225.74.242 (ClassC)
2022-03-22	204.236.218.31 (ClassC)
2022-06-21	3.227.160.79 (ClassC)
2023-10-19	54.145.232.231 (ClassC)
2024-12-14	18.195.103.79 (ClassC)
2025-07-05	34.236.86.94 (ClassC)
2026-02-19	54.183.187.40 (ClassC)

Port 443

HTTP/1.1 200 OKDate: Thu, 19 Feb 2026 12:17:34 GMTServer: ApacheVary: Accept-EncodingTransfer-Encoding: chunkedContent-Type: text/html; charsetUTF-8

!DOCTYPE html>!--if lt IE 7>      html classno-js lt-ie9 lt-ie8 lt-ie7 langen> !endif-->!--if IE 7>         html classno-js lt-ie9 lt-ie8 langen> !endif-->!--if IE 8>         html classno-js lt-ie9 langen> !endif-->!--if gt IE 8>!--> html classno-js langen> !--!endif-->    head>        meta charsetutf-8>        title>Propanc Biopharma, Inc. (PPCB)/title>                                        meta propertyog:site_name contentPropanc Biopharma, Inc.>    meta propertyog:title contentPropanc Biopharma, Inc. (PPCB)>    meta propertyog:type contentwebsite>    meta propertyog:image contenthttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/logo.png>    meta propertyog:url contenthttps://www.propanc.com>        meta nameviewport contentinitial-scale1.0, widthdevice-width>                                link hrefhttps://fonts.googleapis.com/css?familyLato:400,400italic,300,700 relstylesheet typetext/css>                        link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/css/style.css>                                link relshortcut icon hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/favicon.ico>        link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/favicon-16x16.png sizes16x16>        link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/favicon-32x32.png sizes32x32>                        link relapple-touch-icon hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/apple-touch-icon-precomposed.png>        link relapple-touch-icon hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/apple-touch-icon.png>        link relapple-touch-icon sizes57x57 hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/apple-touch-icon-57x57.png>        link relapple-touch-icon sizes60x60 hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/apple-touch-icon-60x60.png>        link relapple-touch-icon sizes72x72 hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/apple-touch-icon-72x72.png>                        link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/android-chrome-36x36.png sizes36x36>        link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/android-chrome-48x48.png sizes48x48>        link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/android-chrome-72x72.png sizes72x72>                        link relmask-icon hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/safari-pinned-tab.svg>                        meta namemsapplication-TileColor content#ffffff>        meta namemsapplication-TileImage contenthttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/mstile-70x70.png>        meta namemsapplication-TileImage contenthttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/mstile-150x150.png>        meta namemsapplication-TileImage contenthttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/mstile-310x150.png>                link relmanifest hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/manifest.json>        meta namemsapplication-config contenthttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/favicons/browserconfig.xml>        !--if lt IE 9>link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/css/ie-8.css>!endif-->                script>    (function(i,s,o,g,r,a,m){iGoogleAnalyticsObjectr;irir||function(){    (ir.qir.q||).push(arguments)},ir.l1*new Date();as.createElement(o),    ms.getElementsByTagName(o)0;a.async1;a.srcg;m.parentNode.insertBefore(a,m)    })(window,document,script,https://www.google-analytics.com/analytics.js,ga);        ga(create, UA-71515148-1, propanc.com);        (function() {        var opts  {};        var prefix  /investor-relations;        if (location.hostname.indexOf(dev-ir.stockpr.com)  0) {            opts.cookiePath  location.pathname.substring(0, location.pathname.indexOf(/, 1) + 1)            opts.page  prefix + location.pathname.substring(location.pathname.indexOf(/, 1));        } else if (location.hostname.match(/^ir\./)) {            opts.page  prefix + location.pathname;        }        ga(send, pageview, opts);    })();/script>    /head>body classpg-1 home>	div classgeneral-wrapper>    	header classbig-header>    div classcontainer>		h1 classlogo>	        a href/>	            img srchttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/header-logo.svg                 width240                height50                altPropanc Biopharma, Inc.>           /a>		/h1>        a classvisible-xs mobile-nav-trigger idshowRight>            div classmeat>/div>            div classmeat>/div>            div classmeat>/div>        /a>		nav classcbp-spmenu cbp-spmenu-vertical cbp-spmenu-right main-nav idmobile-nav>		    			ul classmain-menu>    li classsr-only>a href/>Home/a>/li>            li classhas-children  data-submenu-idsubmenu-about>    a  href/about>About/a>            ul idsubmenu-about>                                                    li class  >a  href/about>Overview/a>/li>                                                    li class  >a  href/about/mission-and-vision>Mission and Vision/a>/li>                                                    li class  >a  href/about/market-need>Market Need/a>/li>                                                    li class  >a  href/about/propanc-difference>Propanc Difference/a>/li>                                                    li class  >a  href/about/management-team>Management Team/a>/li>                                                    li class  >a  href/about/board-of-directors>Board of Directors/a>/li>                                                    li class  >a  href/about/scientific-advisors>Scientific Advisors/a>/li>                    /ul>    /li>            li classhas-children  data-submenu-idsubmenu-product-pipeline>    a  href/product-pipeline>Product Pipeline/a>            ul idsubmenu-product-pipeline>                                                    li class  >a  href/product-pipeline>Overview/a>/li>                                                    li class  >a  href/product-pipeline/prp>PRP/a>/li>                    /ul>    /li>            li class  data-submenu-idsubmenu-technology>    a  href/technology>Technology/a>    /li>            li classhas-children  data-submenu-idsubmenu-news-media>    a  href/news-media>News & Media/a>            ul idsubmenu-news-media>                                                    li class  >a  href/news-media/press-releases>Press Releases/a>/li>                                                    li class  >a  href/news-media/publications>Publications/a>/li>                                                    li class  >a  href/news-media/videos>Videos/a>/li>                                                    li class  >a  href/news-media/in-the-news>In The News/a>/li>                    /ul>    /li>            li classhas-children has-mega-menu  data-submenu-idsubmenu-investors>    a  href/investors>Investors/a>            div classmega-menu second-level same-height-row-disabled>    div classcontainer>        ul classheight>                        li classtitle>a href/investors>Investor Relations/a>/li>                    li>a href/investors/_>Overview/a>/li>                /ul>                    ul classheight>                li classtitle>a href/investors/news-events>News / Events/a>/li>                                    li>a href/investors/news-events/news-events>News / Events/a>/li>                                    li>a href/investors/news-events/press-releases>Press Releases/a>/li>                                    li>a href/investors/news-events/presentations>Presentations/a>/li>                                    li>a href/investors/news-events/ir-calendar>IR Calendar/a>/li>                                    li>a href/investors/news-events/email-alerts>Email Alerts/a>/li>                            /ul>                    ul classheight>                li classtitle>a href/investors/company-information>Company Info/a>/li>                                    li>a href/investors/company-information/company-information>Company Information/a>/li>                                    li>a href/investors/company-information/profile>Profile/a>/li>                                    li>a href/investors/company-information/management-team>Management Team/a>/li>                                    li>a href/investors/company-information/contacts>Contacts/a>/li>                                    li>a href/investors/company-information/faq>FAQ/a>/li>                            /ul>                    ul classheight>                li classtitle>a href/investors/financial-information>Financial Info/a>/li>                                    li>a href/investors/financial-information/financial-information>Financial Information/a>/li>                                    li>a href/investors/financial-information/financials>Financials/a>/li>                                    li>a href/investors/financial-information/financial-results>Financial Results/a>/li>                            /ul>                    ul classheight>                li classtitle>a href/investors/stock-data>Stock Data/a>/li>                                    li>a href/investors/stock-data/stock-data>Stock Data/a>/li>                                    li>a href/investors/stock-data/quote>Quote/a>/li>                                    li>a href/investors/stock-data/charts>Charts/a>/li>                                    li>a href/investors/stock-data/historical-data>Historical Data/a>/li>                                    li>a href/investors/stock-data/form-8937>Form 8937/a>/li>                            /ul>                    ul classheight>                li classtitle>a href/investors/sec-filings>SEC Filings/a>/li>                                    li>a href/investors/sec-filings/sec-filings>SEC Filings/a>/li>                                    li>a href/investors/sec-filings/all-sec-filings>All SEC Filings/a>/li>                                    li>a href/investors/sec-filings/annual-reports>Annual Reports/a>/li>                                    li>a href/investors/sec-filings/quarterly-reports>Quarterly Reports/a>/li>                                    li>a href/investors/sec-filings/section-16-filings>Section 16 Filings/a>/li>                            /ul>                    ul classheight>                li classtitle>a href/investors/corporate-governance>Governance/a>/li>                                    li>a href/investors/corporate-governance/corporate-governance>Corporate Governance/a>/li>                                    li>a href/investors/corporate-governance/board-of-directors>Board of Directors/a>/li>                                    li>a href/investors/corporate-governance/board-committees>Board Committees/a>/li>                                    li>a href/investors/corporate-governance/governance-docs>Governance Documents/a>/li>                            /ul>            /div>/div>    /li>            li class  data-submenu-idsubmenu-contact>    a  href/contact>Contact/a>    /li>    /ul>		/nav>    /div>/header>div classhome-hero video-hero >    div classrow js-same-height-row>        div classcol-md-6 no-padding>            span styledisplay:inline>                a href# idtrigger_button_video>                    div classvideo-box background js-same-height stylebackground: url(https://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/db/242/396/image.jpg);background-position: 50% 50%;background-repeat: no-repeat;background-size: cover;>                        div classplay-box>                            img srchttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/images/icon-play.svg altPlay Video>                        /div>                    /div>                /a>            /span>        /div>        div classcol-md-6 no-padding>            div classtext js-same-height>                div classtext-inner>                    h2>Offering New Hope to Cancer Patients and Their Caregivers/h2>                	p>/p>                	span styledisplay: inline;>a idhome_banner_video classbtn inverse video-btn fancybox-videos href#video_wrapper>img srchttps://d1io3yog0oux5.cloudfront.net/propanc/files/pages/propanc/db/242/extended_description/icon-play.png alt width31 height31>A New Frontier in Cancer Therapy/a>/span>div idvideo_wrapper classvideo-wrap>video controlscontrols crossoriginanonymous>        source srchttps://d1io3yog0oux5.cloudfront.net/_e2428aba3b4a91c58f0d636550388200/propanc/files/videos/Propanc_PRP_Cancer_Stem_Cell_Targeting.mp4 typevideo/mp4>        Your browser does not support the video tag.        track        labelEnglish        kindsubtitles        srclangen        srchttps://d1io3yog0oux5.cloudfront.net/_e2428aba3b4a91c58f0d636550388200/propanc/files/videos/Propanc_PRP_Cancer_Stem_Cell_Targeting.vtt        default />    /video>/div>                	a href/about classbtn inverse >What makes us a life-changing biotech/a>            	/div>            /div>        /div>    /div>!--end row-->/div>!--end home-hero-->div classmodule extra-padding>div classcontainer>	div classrow js-same-height-row>                    div classcol-sm-6 >                div classtext js-same-height bottom-container>		h3>Technology Based on Pancreatic Enzyme Therapy/h3>	p>Our long-term therapy is based on a pancreatic proenzyme formulation that suppresses tumor recurrence and metastasis./p>		a href/technology classbtn bottom-element>How Our Technology Works/a>/div>             /div>                    div classcol-sm-6 col-md-5 col-md-offset-1 full-right-col            >                div classtext js-same-height bottom-container>		h3>Halting Cancer Cells’ Ability to Invade and Metastasize/h3>	p>PRP, our lead candidate, controls cancer cell migration, inhibits tumor blood vessel formation and triggers the cell’s death./p>		a href/product-pipeline/prp classbtn bottom-element>How PRP Works/a>/div>             /div>           	/div>!-- .row -->/div>!-- .container -->/div>div classleft-bg-container>				div classleft-background 				stylebackground: url(https://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/db/262/556/background_image.png);background-position: right bottom;background-repeat: no-repeat;background-size: contain;>/div>				div classmodule gray>					div classcontainer>						div classrow>							div classcol-lg-5 col-md-7 full-right col-md-offset-5 col-lg-offset-7>							    h3>Latest Developments/h3> 							    							        div classdevelopment>        								p>Propanc Biopharma Initiates Development of Bio-Analytical Assay in Preparation for Human Trials/p>                            			                            			div classdark>                            			                            			                            				a href/news-media/press-releases/detail/85/propanc-biopharma-initiates-development-of-bio-analytical target_blank classbtn>Learn More/a>                            			                            			/div>                        			/div>                        			                        									        div classdevelopment>        								p>Propanc Biopharma Commences Drug Discovery Research Collaboration/p>                            			                            			div classdark>                            			                            			                            				a href/news-media/press-releases/detail/81/propanc-biopharma-commences-drug-discovery-research target_blank classbtn>Learn More/a>                            			                            			/div>                        			/div>                        			                        										/div>						/div>					/div>				/div>div classmodule>		div classcontainer>			div classrow>				div classcol-sm-5 full-right col-sm-offset-7>					h3>Significant Market Opportunity for Cancer Therapy/h3>					p>80% of all cancers are solid tumors. We are initially targeting pancreatic, ovarian and colorectal tumors./p>					a href/about/market-need classbtn>View the market need for solid tumors/a>				/div>			/div>		/div>	/div>/div>div classmodule home-news-module medium-padding background extra-padding overlay gradient-overlay dark stylebackground: url(https://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/db/262/558/background_image.jpg);background-position: 50% 50%;background-repeat: no-repeat;background-size: cover;>				div classcontainer>					div classrow js-same-height-row>											div classcol-sm-6>							div classtext bottom-container js-same-height>								h3>Latest News/h3>								div classsingle-new>									div classnews>    p classnews-date>Feb 18, 2026/p>    a hrefhttps://www.propanc.com/news-media/press-releases/detail/187/propanc-biopharma-provides-corporate-update-and-reports>Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results/a>/div>								/div>								a hrefhttps://www.propanc.com/news-media/press-releases classbtn bottom-element>View All Press Releases/a>							/div>						/div>																		div classcol-sm-6 upcoming-event>							div classtext bottom-container js-same-height>								h3>Recent Event/h3>								div classsingle-new>									div classdate>Mar 28, 2024 • 2:00pm EST/div>									a href>Corporate Update Call/a>								/div>								a hrefhttps://ir.propanc.com/ir-calendar classbtn bottom-element>View All Events/a>							/div>						/div>											/div>				/div>			/div>div classmodule extra-padding investor-module quote-box data-symbolPPCB>	div classcontainer>	            		div classquote-box module-info-home data-symbolPPCB>            		h2>Stock Informationspan classmeta>span classtime>/span> | a classcta hrefhttps://ir.propanc.com/quote>View Detailed Stock Info/a>/span>/h2>						div classrow>							div classcol-sm-4>								div classstock-section symbol>									span classvalue>Nasdaq: PPCB/span>									span classvalue-title>Propanc Biopharma, Inc./span>								/div>							/div>							div classcol-sm-4>								div classstock-section price>									span classvalue>span classloader>/span>/span>									span classvalue-title sr-only hidden-xs hidden-sm>Price/span>								/div>							/div>							div classcol-sm-4>								div classstock-section change>									span classvalue>span classeqicon-change-02>/span>span classnumber>span classloader>/span>/span> span classpercent>/span>/span>									span classvalue-title>Change/span>								/div>							/div>						/div>						div classrow>							div classcol-sm-4>								div classstock-section volume>									span classvalue>span classloader>/span>/span>									span classvalue-title>Volume/span>								/div>							/div>							div classcol-sm-4>								div classstock-section day-range>									span classvalue>span classloader>/span>/span>									span classvalue-title>Day Range/span>								/div>							/div>							div classcol-sm-4>								div classstock-section week-range>									span classvalue>span classloader>/span>/span>									span classvalue-title>52 Week Range/span>								/div>							/div>						/div>					/div>	/div>/div>div classinvestor-presentation-module>				div classcontainer>					div classrow js-same-height-row>						div classcol-sm-6 col-md-5>							div classjs-same-height js-height vertical-align>								div classwrapper>									h3>Investor Presentation/h3>									div classdark>										a hrefhttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/db/233/711/pdf/Propanc+Biopharma+Corporate+Presentation.pdf classbtn target_blank>View Investor Presentation/a>									/div>								/div>							/div>						/div>						div classcol-sm-6 col-md-7 js-same-height>							div classouter-image>								img srchttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/db/262/560/image.png altInvestor Presentation>							/div>						/div>					/div>				/div>			/div>div classsubscribe>    div classcontainer>        div classrow dark>        	div classcol-sm-4>            	h3>Get Email Alerts/h3>            /div>            div classcol-sm-5 col-md-6>            	p>Stay informed about our latest news and updates/p>            /div>            div classcol-sm-3 col-md-2>            	a hrefhttps://ir.propanc.com/email-alerts classbtn>Sign Up Today/a>            /div>        /div>    /div>/div>footer>	div classcontainer>		!--div classfooter-social>			a href#>span classeqicon-social-01-linkedin>/span>/a>			a href#>span classeqicon-social-01-twitter>/span>/a>			a href#>span classeqicon-social-01-facebook>/span>/a>		/div-->		div classfooter-links>			    a href/privacy-policy>Privacy Policy/a>    a href/disclaimer>Disclaimer/a>    a href/sitemap>Sitemap/a>			span classcopyright>©2026 a href/>Propanc Biopharma, Inc./a>/span>		/div>	/div>/footer>script idcompanyVars typeapplication/json>{    hCaptchaSiteKey: 778a5748-d323-4b73-a06c-9625642de8bc}/script>script srchttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/js/_js/all.js>/script>script typetext/javascript>  var jqxhr  jq.get( https://www.propanc.com/api/v1/quote, function(data) {    populateQuoteBox(data);  });/script>script>     var $buoop  {    	c: 2    };        function $buo_f() {    	var e  document.createElement(script);    	e.src  //browser-update.org/update.min.js;    	document.body.appendChild(e);    }    try {    	document.addEventListener(DOMContentLoaded, $buo_f, false)    } catch (e) {    	window.attachEvent(onload, $buo_f)    }/script>script srchttps://d1io3yog0oux5.cloudfront.net/_a2d78bc70ebc01640eb983fe26951b11/propanc/files/theme/js/aside/_js/browser-check.min.js async>/script>    	    /div>!-- //general-wrapper -->/body>

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > www.propanc.com

Is this malicious?

DNS Resolutions

Port 443